10 results on '"Wildermann, N."'
Search Results
2. Trade of marine turtles along the Southwestern Coast of the Gulf of Venezuela
- Author
-
Barrios-Garrido, H., primary, Espinoza-Rodríguez, N., additional, Rojas-Cañizales, D., additional, Palmar, J., additional, Wildermann, N., additional, Montiel-Villalobos, M. G., additional, and Hamann, M., additional
- Published
- 2017
- Full Text
- View/download PDF
3. Predicting the exposure of coastal species to plastic pollution in a complex island archipelago.
- Author
-
Critchell K, Hamann M, Wildermann N, and Grech A
- Subjects
- Animals, Coral Reefs, Islands, Queensland, Seasons, Turtles, Wetlands, Wind, Aquatic Organisms growth & development, Environmental Monitoring methods, Models, Theoretical, Plastics analysis, Water Pollutants, Chemical analysis
- Abstract
Plastic pollution in the marine environment is a pervasive and increasing threat to global biodiversity. Prioritising management actions that target marine plastic pollution require spatial information on the dispersal and settlement of plastics from both local and external sources. However, there is a mismatch between the scale of most plastic dispersal studies (regional, national and global) and the scale relevant to management action (local). We use a fine-resolution hydrodynamic model to predict the potential exposure of coastal habitats and species (mangroves, coral reefs and marine turtles) to plastic pollution at the local scale of a management region (the 1,700 km
2 Whitsunday Islands, Queensland, Australia). We assessed the potential exposure of mangroves, coral reefs and marine turtles to plastics during the two dominant wind conditions of the region; the trade wind and monsoon wind seasons. We found that in the trade wind season (April to September) all habitats and species had lower exposure than during the monsoon wind season (October to March). In both wind seasons we found a small proportion of coral reef habitat and large area of turtle habitat were in high potential exposure categories. Unlike coral reefs or marine turtles, mangroves had consistent hotspots of high exposure across wind seasons. Local scale management requires data at fine resolution to capture the variability that occurs at this scale. The outputs of our study can inform the development of conservation resources and local scale management action., (Copyright © 2019 Elsevier Ltd. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
4. Does behaviour affect the dispersal of flatback post-hatchlings in the Great Barrier Reef?
- Author
-
Wildermann N, Critchell K, Fuentes MMPB, Limpus CJ, Wolanski E, and Hamann M
- Abstract
The ability of individuals to actively control their movements, especially during the early life stages, can significantly influence the distribution of their population. Most marine turtle species develop oceanic foraging habitats during different life stages. However, flatback turtles ( Natator depressus ) are endemic to Australia and are the only marine turtle species with an exclusive neritic development. To explain the lack of oceanic dispersal of this species, we predicted the dispersal of post-hatchlings in the Great Barrier Reef (GBR), Australia, using oceanographic advection-dispersal models. We included directional swimming in our models and calibrated them against the observed distribution of post-hatchling and adult turtles. We simulated the dispersal of green and loggerhead turtles since they also breed in the same region. Our study suggests that the neritic distribution of flatback post-hatchlings is favoured by the inshore distribution of nesting beaches, the local water circulation and directional swimming during their early dispersal. This combination of factors is important because, under the conditions tested, if flatback post-hatchlings were entirely passively transported, they would be advected into oceanic habitats after 40 days. Our results reinforce the importance of oceanography and directional swimming in the early life stages and their influence on the distribution of a marine turtle species., Competing Interests: The authors have no competing interests.
- Published
- 2017
- Full Text
- View/download PDF
5. Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions.
- Author
-
Anderson RD, Ohman EM, Holmes DR Jr, Harrington RA, Barsness GW, Wildermann NM, Phillips HR, Topol EJ, and Califf RM
- Subjects
- Aged, Coronary Disease complications, Coronary Disease physiopathology, Coronary Disease therapy, Female, Follow-Up Studies, Heart Failure physiopathology, Humans, Male, Middle Aged, Odds Ratio, Prognosis, Randomized Controlled Trials as Topic, Risk Factors, Stroke Volume, Survival Rate, Angioplasty, Balloon, Coronary, Atherectomy, Coronary, Coronary Disease mortality, Heart Failure complications
- Abstract
Objectives: We sought to determine the prognostic significance of a history of congestive heart failure above that provided by baseline ejection fraction in patients undergoing percutaneous coronary interventions., Background: Left ventricular function is a known predictor of survival in patients with coronary artery disease, as is a history of congestive heart failure. The contribution of heart failure history independent of left ventricular function is unknown., Methods: Data were pooled from four interventional trials and the Duke University database. The combined dataset included 5,260 patients undergoing percutaneous interventions, 334 with and 4,926 without a history of heart failure. Patients were defined by the treating physician as having a clinical history of heart failure at the time of enrollment., Results: The 30-day and 6-month mortality were higher in patients with a clinical history of congestive heart failure than in those without such a history (2% vs. <1%, p=0.002 at 30 days, 5% vs. 1%, p=0.001 at 6 months). Heart failure history did not influence the incidence of myocardial infarction, use of angioplasty or the use of bypass surgery during follow-up. Multivariable analysis revealed that heart failure history added significantly to ejection fraction in predicting intermediate-term (6-month) mortality (p=0.01). Stepwise logistic regression also revealed heart failure history to be an independent predictor of 6-month mortality (odds risk 1.9, 95% confidence interval 1.1 to 3.5)., Conclusions: A clinical history of congestive heart failure is associated with increased early and intermediate-term mortality in patients undergoing percutaneous revascularization. Congestive heart failure history appears to provide prognostic information independent of that available from a patient's left ventricular function. These findings suggest that patients with a clinical history of congestive heart failure who undergo a percutaneous intervention should be closely monitored, especially those with the lowest ejection fractions.
- Published
- 1998
- Full Text
- View/download PDF
6. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
- Author
-
Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, and Armstrong PW
- Subjects
- Aged, Cardiac Catheterization, Coronary Angiography, Electrocardiography, Female, Humans, Male, Middle Aged, Myocardial Infarction physiopathology, Prognosis, Treatment Outcome, Ventricular Function, Left drug effects, Fibrinolytic Agents therapeutic use, Myocardial Infarction drug therapy, Streptokinase therapeutic use, Thrombolytic Therapy, Tissue Plasminogen Activator therapeutic use
- Abstract
Background: Although the stratification of patients with myocardial infarction into ECG subsets based on the presence or absence of new Q waves has important clinical and prognostic utility, systematic evaluation of the impact of thrombolytic therapy on the subsequent development and prognosis of non-Q-wave infarction has been limited to date., Methods and Results: We examined 12-lead ECG, coronary anatomy, left ventricular function, and mortality among 2046 patients with ST-segment elevation infarction from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries angiographic subset to gain further insight into the pathophysiology and prognosis of Q- versus non-Q-wave infarction in the thrombolytic era. Non-Q-wave infarction developed in 409 patients (20%) after thrombolytic therapy. Compared with Q-wave patients, non-Q-wave patients were more likely to present with lesser ST-segment elevation in a nonanterior location. The infarct-related artery in non-Q-wave patients was more likely to be nonanterior (67% versus 58%, P=.012) and distally located (33% versus 39%, P=.021). Early (90-minute, 77% versus 65%, P=.001) and complete (54% versus 44%, P<.001) infarct-related artery patency was greater among the non-Q-wave group. Non-Q-wave patients had better global (ejection fraction, 66% versus 57%; P<.0001) and regional left ventricular function (10 versus 24 abnormal chords, P=.0001). In-hospital, 30-day, 1-year, and 2-year (6.3% versus 10.1%, P=.02) mortality rates were lower among non-Q-wave patients., Conclusions: The excellent prognosis among the subgroup of patients who develop non-Q-wave infarction after thrombolysis is related to early, complete, and sustained infarct-related artery patency with resultant limitation of left ventricular infarction and dysfunction.
- Published
- 1998
- Full Text
- View/download PDF
7. Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.
- Author
-
Khan MM, Ellis SG, Aguirre FV, Weisman HF, Wildermann NM, Califf RM, Topol EJ, and Kleiman NS
- Subjects
- Abciximab, Aged, Antibodies, Monoclonal therapeutic use, Coronary Angiography, Coronary Thrombosis drug therapy, Double-Blind Method, Female, Humans, Immunoglobulin Fab Fragments therapeutic use, Male, Middle Aged, Platelet Aggregation Inhibitors therapeutic use, Prospective Studies, Treatment Outcome, Angioplasty, Balloon, Coronary, Coronary Thrombosis complications, Myocardial Infarction complications, Myocardial Infarction therapy
- Abstract
Objectives: We sought to evaluate the impact of angiographically visible thrombus on short- and long-term clinical outcomes after percutaneous transluminal coronary angioplasty (PTCA)., Background: Intracoronary thrombus is frequently seen on angiography in patients with acute ischemic coronary syndromes or complex lesion morphology, or both, and is often considered to predict a higher rate of complications in patients undergoing PTCA., Methods: Prospectively collected data from 2,099 patients undergoing high risk PTCA in the Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications (EPIC) trial were analyzed. In addition to aspirin and heparin, patients were randomized to receive either abciximab bolus and infusion, abciximab bolus alone or placebo. Based on an angiographic core laboratory interpretation, patients were classified into three groups: thrombus absent, thrombus possible or thrombus present. The primary end point at 30 days was the composite of death, myocardial infarction or urgent revascularization. The 6-month end point was the composite of death, myocardial infarction or any revascularization., Results: Although abrupt closure was most common in patients with thrombus present compared with thrombus absent or possible (13%, 10.0% and 7.4%, respectively), neither the 30-day nor the 6-month clinical end points were different among the three groups (9%, 11% and 11.7%, respectively, and 30%, 34% and 31%, respectively). Most notably, the benefit of treatment with abciximab was present in all three thrombus groups, and the magnitude of benefit was not different among the thrombus groups., Conclusions: In high risk patients undergoing percutaneous coronary revascularization, features of thrombus on the preprocedure angiogram do not indicate an augmented risk of adverse clinical outcomes. Abciximab therapy reduces the rate of adverse outcomes regardless of the presence of thrombus and should therefore not necessarily be reserved for patients whose angiograms have features of intraluminal thrombus.
- Published
- 1998
- Full Text
- View/download PDF
8. Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction.
- Author
-
Shah A, Wagner GS, Califf RM, Boineau RE, Green CL, Wildermann NM, Trollinger KM, Pope JE, and Krucoff MW
- Subjects
- Aged, Angina Pectoris etiology, Female, Heart Failure etiology, Humans, Male, Middle Aged, Myocardial Infarction complications, Myocardial Infarction diagnosis, Myocardial Infarction mortality, Prognosis, Electrocardiography, Myocardial Infarction physiopathology
- Abstract
Objectives: We sought to determine the prognostic significance of simultaneous versus independent resolution of ST segment depression that occurs concomitant with ST segment elevation during acute myocardial infarction (AMI)., Background: ST segment depression in leads other than those showing ST segment elevation during AMI is a common phenomenon. Whether this indicates adverse outcomes remains controversial. We hypothesized that the timing of ST segment depression resolution relative to ST segment elevation resolution might differentiate between a high risk group and a low risk group of patients., Methods: Continuous 12-lead ST segment monitoring was performed after thrombolytic therapy for AMI in 413 patients, 261 of whom met technical criteria for analysis. Blinded analysis of ST segment depression resolution patterns was used to group patients as follows: 1) no ST segment depression at any time (control group); 2) ST segment depression resolving simultaneously with ST segment elevation (simultaneous group); and 3) ST segment depression persisting after ST segment elevation resolution (independent group). These patterns were correlated with the outcomes-recurrent angina, reinfarction, heart failure and death-using chi-square analysis and the Fisher exact test for categoric variables and the Wilcoxon rank-sum test for continuous variables., Results: The incidence of recurrent angina, reinfarction and heart failure was similar among the three groups. In-hospital mortality, however, was significantly higher in the independent group (13%) than either the simultaneous group (1%, p < 0.001) or the control group (0%, p = 0.002)., Conclusions: Continuous analysis of ST segment resolution identifies, among patients with AMI with concomitantly occurring ST segment elevation and depression, a subgroup with increased in-hospital mortality. The pathogenic mechanism of increased mortality is not currently known.
- Published
- 1997
- Full Text
- View/download PDF
9. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era.
- Author
-
Bengtson JR, Kaplan AJ, Pieper KS, Wildermann NM, Mark DB, Pryor DB, Phillips HR 3rd, and Califf RM
- Subjects
- Academic Medical Centers, Age Factors, Aged, Angioplasty, Balloon, Coronary standards, Cardiac Catheterization, Cardiac Output, Cardiotonic Agents therapeutic use, Combined Modality Therapy, Coronary Angiography, Creatine Kinase blood, Decision Trees, Female, Follow-Up Studies, Hospital Mortality, Humans, Intra-Aortic Balloon Pumping standards, Isoenzymes, Logistic Models, Male, Middle Aged, Myocardial Infarction diagnosis, Myocardial Reperfusion methods, North Carolina epidemiology, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Prospective Studies, Shock, Cardiogenic etiology, Shock, Cardiogenic mortality, Stroke Volume, Survival Analysis, Thrombolytic Therapy standards, Treatment Outcome, Vasoconstrictor Agents therapeutic use, Myocardial Infarction complications, Myocardial Reperfusion standards, Shock, Cardiogenic therapy
- Abstract
Objectives: The purpose of this study is to describe the outcome in cardiogenic shock treated with aggressive reperfusion therapy and to identify factors predictive of in-hospital and long-term mortality., Background: Cardiogenic shock is the most common cause of death in patients admitted to the coronary care unit. Although studies have reported lower mortality rates in shock treated with angioplasty, few studies have described a cohort of patients with shock who were not selected because they were most likely to benefit from reperfusion therapy., Methods: A consecutive series of 200 patients admitted with acute myocardial infarction complicated by cardiogenic shock were studied., Results: The in-hospital mortality rate was 53%. Variables with significant univariable association with in-hospital death included patency of the infarct-related artery, patient age, lowest cardiac index, highest arteriovenous oxygen difference and left main coronary artery disease. The most important independent predictors of in-hospital death were patency of the infarct-related artery, cardiac index and peak creatine kinase, MB fraction. The mortality rate in patients with patent infarct-related arteries was 33% versus 75% in those with closed arteries and 84% in those in whom arterial patency was unknown. Patients who survived to hospital discharge were followed up for a median of 2 years, with a mortality rate of 18% after 1 year. The best descriptors of the relation between these variables and postdischarge mortality included age, peak creatine kinase, ejection fraction and patency of the infarct-related artery., Conclusions: In a large consecutive series of patients with cardiogenic shock with complete follow-up, patency of the infarct-related artery was most strongly associated with in-hospital and long-term mortality. This finding supports an aggressive interventional strategy in patients with cardiogenic shock.
- Published
- 1992
- Full Text
- View/download PDF
10. The laboratory method as a variable in the interpretation of serum bilirubin fractionation.
- Author
-
Killenberg PG, Stevens RD, Wildermann RF, and Wildermann NM
- Subjects
- Adult, Cholelithiasis blood, Diagnosis, Differential, Gilbert Disease blood, Humans, Male, Bilirubin blood, Hyperbilirubinemia blood, Spectrum Analysis methods
- Abstract
Fractionation of the serum bilirubin into direct and indirect-reacting components has been used in the differentiation of patients with hepatobiliary disease from those with unconjugated hyperbilirubinemia. Previous studies have shown that patients with indirect hyperbilirubinemia usually have total serum bilirubin concentrations less than 5 mg/dl. Therefore, clinically useful methods of fractionating bilirubin must yield reliable results in patients with mild hyperbilirubinemia. Experience with 4 patients with mild hyperbilirubinemia indicated that conflicting results could be obtained from two different laboratories. Therefore, a panel of hyperbilirubinemic sera were submitted to four different laboratories. While there was general agreement in sera containing high concentrations of bilirubin, marked variations were observed in the results reported on sera with less than 5 mg/dl total bilirubin. Finally, clinical and other laboratory parameters were reviewed in patients who had had bilirubin fractionation performed by one or the other of two routine laboratories. In one laboratory, bilirubin fractionation correctly distinguished patients with hepatobiliary disease, while the other laboratory was not able to differentiate patients on the basis of this test. These data suggest that despite the general reported agreement in standard methods for bilirubin fractionation there may be marked differences among methods in ability to reliably fractionate sera with total bilirubin concentrations less than 5 mg/dl.
- Published
- 1980
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.